Angiotensin‐converting enzyme inhibitors vs ACEi plus angiotensin receptor blockers
Fatal or nonfatal myocardial infarction · people with diabetes and kidney disease
Angiotensin‐converting‐enzyme inhibitors (ACEi) alone showed no clear difference in fatal or nonfatal myocardial infarction Median compared with ACEi plus angiotensin receptor blockers (low certainty).
1 finding from 1 review
- Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic… 2024 · Cochrane Headline outcomes onlyRR 0.44 [0.17, 1.12]3 studies · 880 participantsLow